Tectonic Therapeutic (TECX) Enterprise Value (2017 - 2026)
Tectonic Therapeutic (TECX) has 10 years of Enterprise Value data on record, last reported at -$236.9 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 22.65% to -$236.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$236.9 million, a 22.65% increase, with the full-year FY2025 number at -$254.4 million, down 80.11% from a year prior.
- Enterprise Value reached -$236.9 million in Q1 2026 per TECX's latest filing, up from -$254.4 million in the prior quarter.
- Over the last five years, Enterprise Value for TECX hit a ceiling of -$6.6 million in Q3 2023 and a floor of -$306.2 million in Q1 2025.
- A 5-year average of -$146.2 million and a median of -$141.2 million in 2024 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: skyrocketed 94.32% in 2023, then plummeted 2305.79% in 2024.
- Tracing TECX's Enterprise Value over 5 years: stood at -$92.8 million in 2022, then surged by 68.71% to -$29.1 million in 2023, then crashed by 386.16% to -$141.2 million in 2024, then plummeted by 80.11% to -$254.4 million in 2025, then rose by 6.88% to -$236.9 million in 2026.
- Business Quant data shows Enterprise Value for TECX at -$236.9 million in Q1 2026, -$254.4 million in Q4 2025, and -$269.0 million in Q3 2025.